⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Aclaris Therapeutics, Inc.

$6.05
-0.12 (-1.94%)

Market Capitalization:

$845.94M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Aclaris Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

-0.12(-1.94%)
Open$6.17
Close$6.05
Low$6.05
Low Change-0.12 (-1.94%)
High$6.17
High Change+0.00 (+0.00%)
Range$0.12
Volume103.853K
Dollar Volume$628.31K

Regular Trading Hours Yesterday

+0.21(+3.44%)
Open$5.97
Close$6.17
Low$5.87
Low Change-0.10 (-1.59%)
High$6.20
High Change+0.23 (+3.86%)
Range$0.33
Volume1.625M
Dollar Volume$10.03M

Premarket Yesterday

+0.02(+0.34%)
Open$5.93
Close$5.95
Low$5.93
Low Change0.00 (0.00%)
High$5.95
High Change+0.02 (+0.34%)
Range$0.02
Volume11.165K
Dollar Volume$66.43K

Aclaris Therapeutics News

There is no current news for this stock at the moment.

Aclaris Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Aclaris Therapeutics Moving Averages

5 Day Moving Average (SMA5)$6.08
10 Day Moving Average (SMA10)$6.16
20 Day Moving Average (SMA20)$6.11
50 Day Moving Average (SMA50)$5.75
100 Day Moving Average (SMA100)$5.13
200 Day Moving Average (SMA200)$4.22

Aclaris Therapeutics Statistics

Average Volume (30 Days)1.89M
P/E Ratio (Current)-11.67
EPS (Current)-$0.51
Dividend Yield0.00%
Free Cash Flow-$62.18M
Cash Ratio0.68
Current Ratio3.46
Quick Ratio3.46
Debt to Equity0.00
Enterprise Value$856.67M
EV to EBITDA-10.03
EV to Sales104.23
Price to Book7.03
Price to Cash Flow
Price to Free Cash Flow
Price to Sales106.56
Return on Assets-0.42%
Return on Equity-0.61%

Aclaris Therapeutics Stock Splits

There have been no stock splits for Aclaris Therapeutics (ACRS).

Aclaris Therapeutics Dividends

There have been no dividends for Aclaris Therapeutics (ACRS).